Tectonic Therapeutic | AVRO - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Celltrion KRW 412.27B 348.97B 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
MacroGenics USD 70M 256K 2025-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 60.57B 1.08B 2026-03
Pharma Mar EUR 33.16M 3.52M 2026-03
Qiagen NV USD 1.65B 15.23M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 13.84B 1.88B 2026-03
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Sartorius EUR 3.34B 152.8M 2026-03
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Takeda JPY 4.37T 99.51B 2026-03
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03